https://www.marketscreener.com/quote/stock/BIOCRYST-PHARMACEUTICALS--8534/news/BioCryst-Initiates-OPuS-2-A-Clinical-Trial-of-BCX4161-in-Patients-With-Hereditary-Angioedema-19563293/?utm_source=telegram&utm_medium=social&utm_campaign=share